Switzerland -
Italian -
Swissmedic (Swiss Agency for Therapeutic Products)
oxycodon naloxon spirig hc 20 mg/10 mg retardtabletten
spirig healthcare ag - oxycodoni hydrochloridum, naloxoni hydrochloridum anhydricum - retardtabletten - oxycodoni hydrochloridum 20 mg, naloxoni hydrochloridum anhydricum 10 mg ut naloxoni hydrochloridum dihydricum, poly(vinylis acetas), povidonum k 27-32, natrii laurilsulfas, cellulosum microcristallinum, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), talcum, macrogolum 3350, e 171, pro compresso obducto corresp. natrium 0.05 mg. - un narcotico analgesico - synthetika
Switzerland -
Italian -
Swissmedic (Swiss Agency for Therapeutic Products)
oxycodon naloxon spirig hc 30 mg/15 mg retardtabletten
spirig healthcare ag - oxycodoni hydrochloridum, naloxoni hydrochloridum anhydricum - retardtabletten - oxycodoni hydrochloridum 30 mg, naloxoni hydrochloridum anhydricum 15 mg ut naloxoni hydrochloridum dihydricum, poly(vinylis acetas), povidonum k 27-32, natrii laurilsulfas, cellulosum microcristallinum, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), talcum, macrogolum 3350, e 171, e 172 (flavum), pro compresso obducto corresp. natrium 0.05 mg. - un narcotico analgesico - synthetika
Switzerland -
Italian -
Swissmedic (Swiss Agency for Therapeutic Products)
oxycodon naloxon spirig hc 40 mg/20 mg retardtabletten
spirig healthcare ag - oxycodoni hydrochloridum, naloxoni hydrochloridum anhydricum - retardtabletten - oxycodoni hydrochloridum 40 mg, naloxoni hydrochloridum anhydricum 20 mg ut naloxoni hydrochloridum dihydricum, poly(vinylis acetas), povidonum k 27-32, natrii laurilsulfas, cellulosum microcristallinum, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), talcum, macrogolum 3350, e 171, e 172 (rubrum), pro compresso obducto corresp. natrium 0.06 mg. - un narcotico analgesico - synthetika
Italy -
Italian -
AIFA (Agenzia Italiana del Farmaco)
apoklisi
neopharmed gentili s.p.a. - ossicodone - ossicodone
European Union -
Italian -
EMA (European Medicines Agency)
rizmoic
shionogi b.v. - naldemedine tosilas - stipsi - farmaci per la costipazione, antagonisti del recettore oppioide periferico - rizmoic è indicato per il trattamento della costipazione indotta da oppioidi (oic) in pazienti adulti che sono stati precedentemente trattati con un lassativo.
Italy -
Italian -
AIFA (Agenzia Italiana del Farmaco)
ossicodone e naloxone g.l.
g.l. pharma gmbh - oxicodone, combinazioni - oxicodone, combinazioni
Italy -
Italian -
AIFA (Agenzia Italiana del Farmaco)
elatrex
mylan s.p.a. - oxicodone, combinazioni - oxicodone, combinazioni
Switzerland -
Italian -
Swissmedic (Swiss Agency for Therapeutic Products)
buvidal 8 mg depot-injektionslösung
future health pharma gmbh - buprenorphinum - depot-injektionslösung - buprenorphinum 8 mg, ethanolum anhydricum 15.31 mg, phosphatidylcholinum ex soja, glyceroli dioleas, ad solutionem pro 0.16 ml. - terapia sostitutiva in caso di dipendenza da oppiacei - synthetika
Switzerland -
Italian -
Swissmedic (Swiss Agency for Therapeutic Products)
buvidal 16 mg depot-injektionslösung
future health pharma gmbh - buprenorphinum - depot-injektionslösung - buprenorphinum 16 mg, ethanolum anhydricum 30.62 mg, phosphatidylcholinum ex soja, glyceroli dioleas, ad solutionem pro 0.32 ml. - terapia sostitutiva in caso di dipendenza da oppiacei - synthetika
Switzerland -
Italian -
Swissmedic (Swiss Agency for Therapeutic Products)
buvidal 24 mg depot-injektionslösung
future health pharma gmbh - buprenorphinum - depot-injektionslösung - buprenorphinum 24 mg, ethanolum anhydricum 45.94 mg, phosphatidylcholinum ex soja, glyceroli dioleas, ad solutionem pro 0.48 ml. - terapia sostitutiva in caso di dipendenza da oppiacei - synthetika